Notes
- Reserved for the treatment of suspected/documented invasive aspergillosis
- Reserved for the treatment of infections caused by S. apiospermum, Fusarium species (including F. solani) and non-albicans Candida species in patients intolerant of, or refractory to other therapy
Dosing
- No dose adjustment
- IV formulation okay in renal failure
- Contact Infectious Diseases pharmacy for dosing assistance (RRMC p99917; SMH p91059)